As of today, VISION technology has now contributed to over 7,000 randomizations across the U.S. and Europe.
At just a year since its launch, VISION is already making clinical trials more accessible to all on a global scale. We’re proud of the impact our team and technology are making in advancing clinical research.
Here’s to the next 7,000 and beyond!
